Kontafarma China Holdings Limited (HKG:1312)

Kontafarma China Holdings Statistics

Total Valuation

HKG:1312 has a market cap or net worth of HKD 167.66 million. The enterprise value is 228.27 million.

Market Cap	167.66M
Enterprise Value	228.27M

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1312 has 5.59 billion shares outstanding.

Current Share Class	5.59B
Shares Outstanding	5.59B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.90B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.18
PB Ratio	0.35
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.53
EV / Sales	0.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.43.

Current Ratio	0.80
Quick Ratio	0.59
Debt / Equity	0.43
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.17

Financial Efficiency

Return on equity (ROE) is -67.12% and return on invested capital (ROIC) is -7.31%.

Return on Equity (ROE)	-67.12%
Return on Assets (ROA)	-2.12%
Return on Invested Capital (ROIC)	-7.31%
Return on Capital Employed (ROCE)	-7.45%
Weighted Average Cost of Capital (WACC)	4.20%
Revenue Per Employee	1.40M
Profits Per Employee	-653,203
Employee Count	655
Asset Turnover	0.69
Inventory Turnover	4.53

Taxes

In the past 12 months, HKG:1312 has paid 27.83 million in taxes.

Income Tax	27.83M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.14% in the last 52 weeks. The beta is -0.00, so HKG:1312's price volatility has been lower than the market average.

Beta (5Y)	-0.00
52-Week Price Change	+7.14%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	51.78
Average Volume (20 Days)	2,259,900

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1312 had revenue of HKD 914.71 million and -427.85 million in losses. Loss per share was -0.08.

Revenue	914.71M
Gross Profit	513.64M
Operating Income	-44.90M
Pretax Income	-454.73M
Net Income	-427.85M
EBITDA	-10.67M
EBIT	-44.90M
Loss Per Share	-0.08

Balance Sheet

The company has 66.06 million in cash and 203.68 million in debt, with a net cash position of -137.62 million or -0.02 per share.

Cash & Cash Equivalents	66.06M
Total Debt	203.68M
Net Cash	-137.62M
Net Cash Per Share	-0.02
Equity (Book Value)	476.26M
Book Value Per Share	0.10
Working Capital	-90.79M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	34.23M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 56.15%, with operating and profit margins of -4.91% and -46.77%.

Gross Margin	56.15%
Operating Margin	-4.91%
Pretax Margin	-49.71%
Profit Margin	-46.77%
EBITDA Margin	-1.17%
EBIT Margin	-4.91%
FCF Margin	n/a

Dividends & Yields

HKG:1312 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-255.19%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 20, 2015. It was a forward split with a ratio of 5.

Last Split Date	Jan 20, 2015
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2